226 related articles for article (PubMed ID: 24455612)
1. Positron emission tomography-computed tomography in the management of lung cancer: An update.
Sharma P; Singh H; Basu S; Kumar R
South Asian J Cancer; 2013 Jul; 2(3):171-8. PubMed ID: 24455612
[TBL] [Abstract][Full Text] [Related]
2. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
Facey K; Bradbury I; Laking G; Payne E
Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in the management of non-small cell lung cancer.
Vansteenkiste JF; Stroobants SG
Hematol Oncol Clin North Am; 2004 Feb; 18(1):269-88. PubMed ID: 15005293
[TBL] [Abstract][Full Text] [Related]
5. The role of new PET tracers for lung cancer.
Szyszko TA; Yip C; Szlosarek P; Goh V; Cook GJ
Lung Cancer; 2016 Apr; 94():7-14. PubMed ID: 26973200
[TBL] [Abstract][Full Text] [Related]
6. The lung cancers: staging and response, CT,
Owens C; Hindocha S; Lee R; Millard T; Sharma B
Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296
[TBL] [Abstract][Full Text] [Related]
7. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Yap CS; Czernin J; Fishbein MC; Cameron RB; Schiepers C; Phelps ME; Weber WA
Chest; 2006 Feb; 129(2):393-401. PubMed ID: 16478857
[TBL] [Abstract][Full Text] [Related]
9. Low-sensitivity FDG-PET studies: less common lung neoplasms.
Erasmus JJ; Macapinlac HA
Semin Nucl Med; 2012 Jul; 42(4):255-60. PubMed ID: 22681674
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer.
Hockmann J; Hautzel H; Darwiche K; Eberhard W; Stuschke M; Aigner C; Herrmann K; Plönes T
Asian Cardiovasc Thorac Ann; 2023 Jul; 31(6):506-511. PubMed ID: 37438928
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A;
Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534
[TBL] [Abstract][Full Text] [Related]
12. Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review.
Dahlsgaard-Wallenius SE; Hildebrandt MG; Johansen A; Vilstrup MH; Petersen H; Gerke O; Høilund-Carlsen PF; Morsing A; Andersen TL
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):584-591. PubMed ID: 32719914
[TBL] [Abstract][Full Text] [Related]
13. Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.
Cuaron J; Dunphy M; Rimner A
Front Oncol; 2012; 2():208. PubMed ID: 23316478
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.
Gilbert FJ; Harris S; Miles KA; Weir-McCall JR; Qureshi NR; Rintoul RC; Dizdarevic S; Pike L; Sinclair D; Shah A; Eaton R; Clegg A; Benedetto V; Hill JE; Cook A; Tzelis D; Vale L; Brindle L; Madden J; Cozens K; Little LA; Eichhorst K; Moate P; McClement C; Peebles C; Banerjee A; Han S; Poon FW; Groves AM; Kurban L; Frew AJ; Callister ME; Crosbie P; Gleeson FV; Karunasaagarar K; Kankam O; George S
Health Technol Assess; 2022 Mar; 26(17):1-180. PubMed ID: 35289267
[TBL] [Abstract][Full Text] [Related]
16. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
17. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Rasheed R; Al-Kandari F; Ghanem M; Marafi F; Usmani S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):511-515. PubMed ID: 32102532
[TBL] [Abstract][Full Text] [Related]
18. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
20. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
